Search
Amplify Weight Loss Drug & Treatment ETF
THNRAdd to Watchlist
25.915USD
+0.173+0.67%
Close 11-06 16:00（ET）
200.00Volume
5.14KTurnover
Today
+0.67%
5 Days
-0.12%
1 Month
+4.91%
6 Months
+4.71%
Year to Date
+2.76%
1 Year
+12.07%
Key Figures
25.670Open
25.742Prev. Close
25.915High
25.660Low
200.00Volume
5.14KTurnover
1.74Volume Ratio
27.94052wk High
23.40052wk Low
1.40KAvg Volume
1.72%Div Yield
0.413Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
24.681NAV
USDNAV Currency
4.42P/B
18.88Price to earnings ratio
Amplify Weight Loss Drug & Treatment ETF Profile
Ticker SymbolTHNR
Asset ClassEquity
Fund ManagerAmplify
DomicileUS
Expense Ratio0.59%
Founded at2024-05-21
Tracking IndexVettaFi Weight Loss Drug & Treatment Index - Benchmark TR Net
THNR was created on 2024-05-21 by Amplify. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 5.61m in AUM and 22 holdings. THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
Eli Lilly and Co
LLY
1354.000
-10.730
-0.79%
503.00
11.45%
$657.26K
Novo Nordisk AS ADR
NVO
40.310
+0.010
+0.02%
12.84K
8.82%
$506.08K
Amgen Inc
AMGN
460.420
+0.140
+0.03%
788.00
6.14%
$352.46K
4
Roche Holding AG Ordinary Shares new
ROP.SW
--
0.000
--
708.00
5.87%
$337.09K
5
Pfizer Inc
PFE
29.390
-0.060
-0.20%
10.90K
5.78%
$331.46K
6
AbbVie Inc
ABBV
291.310
+3.070
+1.07%
1.15K
5.71%
$327.68K
7
AstraZeneca PLC
AZN.L
--
0.000
--
1.89K
5.68%
$325.81K
8
Gilead Sciences Inc
GILD
166.890
-0.680
-0.41%
2.02K
5.54%
$318.15K
9
Regeneron Pharmaceuticals Inc
REGN
904.350
+1.450
+0.16%
380.00
5.42%
$311.25K
10
Merck & Co Inc
MRK
146.730
-0.210
-0.14%
2.02K
5.20%
$298.16K
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
Technical Indicators
Neutral
Summary
Buy
Moving Average
Strong buy
Amplify Weight Loss Drug & Treatment ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Amplify Weight Loss Drug & Treatment ETF (THNR)?
The current price of Amplify Weight Loss Drug & Treatment ETF (THNR) is 25.91. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Amplify Weight Loss Drug & Treatment ETF?
The 52-week high of Amplify Weight Loss Drug & Treatment ETF is 27.94. Please refer to the page timestamp for the latest data.
What is the 52-week low of Amplify Weight Loss Drug & Treatment ETF?
The 52-week low of Amplify Weight Loss Drug & Treatment ETF is 23.40. Please refer to the page timestamp for the latest data.
What is the NAV of Amplify Weight Loss Drug & Treatment ETF?
The NAV of Amplify Weight Loss Drug & Treatment ETF is 24.68 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is Amplify Weight Loss Drug & Treatment ETF (THNR) performing?
The trading turnover of Amplify Weight Loss Drug & Treatment ETF (THNR) is 5.14K. Its price changed by 6.09% over the past month, while its one-year return is 10.84%. View the Amplify Weight Loss Drug & Treatment ETF price chart for more details.
Is Amplify Weight Loss Drug & Treatment ETF (THNR) a safe investment?
No investment is completely risk-free. The risk level of Amplify Weight Loss Drug & Treatment ETF (THNR) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.